Literature DB >> 17564440

Model for antibiotic optimization via neoglycosylation: synthesis of liponeoglycopeptides active against VRE.

Byron R Griffith1, Candace Krepel, Xun Fu, Sophie Blanchard, Aqeel Ahmed, Charles E Edmiston, Jon S Thorson.   

Abstract

The neoglycosylation of a methoxyamine-appended vancomycin aglycon with all possible N'-decanoylglucopyranose and N'-biphenoylglucopyranose regioisomers led to the production of a focused set of liponeoglycopeptide variants in good yields and with excellent stereoselectivity. High-throughput antibacterial assays employing a unique set of vancomycin-resistant Enterococci faecalis and Enterococci faecium clinical isolates revealed that the nature and regiochemistry of glycosyl lipidation modulated vancomycin-resistent Enterococci potency. In contrast to prior work with lipoglycopeptides, this study reveals the glucose C3' or C4' as the optimal position for neoglycopeptide lipidation. This purely chemical method for the diversification of the glycolipid portion of lipoglycopeptide antibiotics is simple to perform on a large scale, requires minimal synthetic effort in sugar donor preparation, and provides access to highly active antibiotics that are not easily prepared by other state-of-the-art methods.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17564440     DOI: 10.1021/ja068602r

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  21 in total

1.  Assessment of chemoselective neoglycosylation methods using chlorambucil as a model.

Authors:  Randal D Goff; Jon S Thorson
Journal:  J Med Chem       Date:  2010-10-25       Impact factor: 7.446

2.  Catalytic site-selective thiocarbonylations and deoxygenations of vancomycin reveal hydroxyl-dependent conformational effects.

Authors:  Brandon S Fowler; Kai M Laemmerhold; Scott J Miller
Journal:  J Am Chem Soc       Date:  2012-05-23       Impact factor: 15.419

3.  Total syntheses and initial evaluation of [Ψ[C(═S)NH]Tpg⁴]vancomycin, [Ψ[C(═NH)NH]Tpg⁴]vancomycin, [Ψ[CH₂NH]Tpg⁴]vancomycin, and their (4-chlorobiphenyl)methyl derivatives: synergistic binding pocket and peripheral modifications for the glycopeptide antibiotics.

Authors:  Akinori Okano; Atsushi Nakayama; Kejia Wu; Erick A Lindsey; Alex W Schammel; Yiqing Feng; Karen C Collins; Dale L Boger
Journal:  J Am Chem Soc       Date:  2015-03-09       Impact factor: 15.419

4.  A fused [3.3.0]-neoglycoside lactone derived from glucuronic acid.

Authors:  Matthew W Schombs; Ryan A Davis; James C Fettinger; Jacquelyn Gervay-Hague
Journal:  Acta Crystallogr C       Date:  2013-08-07       Impact factor: 1.172

5.  Warfarin glycosylation invokes a switch from anticoagulant to anticancer activity.

Authors:  Pauline Peltier-Pain; Shannon C Timmons; Agnès Grandemange; Etienne Benoit; Jon S Thorson
Journal:  ChemMedChem       Date:  2011-06-28       Impact factor: 3.466

Review 6.  The impact of enzyme engineering upon natural product glycodiversification.

Authors:  Gavin J Williams; Richard W Gantt; Jon S Thorson
Journal:  Curr Opin Chem Biol       Date:  2008-10       Impact factor: 8.822

Review 7.  Increasing carbohydrate diversity via amine oxidation: aminosugar, hydroxyaminosugar, nitrososugar, and nitrosugar biosynthesis in bacteria.

Authors:  Shannon C Timmons; Jon S Thorson
Journal:  Curr Opin Chem Biol       Date:  2008-04-18       Impact factor: 8.822

8.  Natural product disaccharide engineering through tandem glycosyltransferase catalysis reversibility and neoglycosylation.

Authors:  Pauline Peltier-Pain; Karen Marchillo; Maoquan Zhou; David R Andes; Jon S Thorson
Journal:  Org Lett       Date:  2012-09-17       Impact factor: 6.005

9.  Enhancing the divergent activities of betulinic acid via neoglycosylation.

Authors:  Randal D Goff; Jon S Thorson
Journal:  Org Lett       Date:  2009-01-15       Impact factor: 6.005

10.  Synthesis and antibacterial activity of doxycycline neoglycosides.

Authors:  Jianjun Zhang; Larissa V Ponomareva; Karen Marchillo; Maoquan Zhou; David R Andes; Jon S Thorson
Journal:  J Nat Prod       Date:  2013-08-29       Impact factor: 4.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.